Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Adding insult to injury: the spectrum of tubulointerstitial responses in acute kidney injury
Megan L. Baker, Lloyd G. Cantley
Megan L. Baker, Lloyd G. Cantley
View: Text | PDF
Review

Adding insult to injury: the spectrum of tubulointerstitial responses in acute kidney injury

  • Text
  • PDF
Abstract

Acute kidney injury (AKI) encompasses pathophysiology ranging from glomerular hypofiltration to tubular cell injury and outflow obstruction. This Review will focus on the tubulointerstitial processes that underlie most cases of AKI. Tubular epithelial cell (TEC) injury can occur via distinct insults, including ischemia, nephrotoxins, sepsis, and primary immune-mediated processes. Following these initial insults, tubular cells can activate survival and repair responses or they can develop mitochondrial dysfunction and metabolic reprogramming, cell-cycle arrest, and programmed cell death. Developing evidence suggests that the fate of individual tubular cells to survive and proliferate or undergo cell death or senescence is frequently determined by a biphasic immune response with initial proinflammatory macrophage, neutrophil, and lymphocyte infiltration exacerbating injury and activating programmed cell death, while alternatively activated macrophages and specific lymphocyte subsets subsequently modulate inflammation and promote repair. Functional recovery requires that this reparative phase supports proteolytic degradation of tubular casts, proliferation of surviving TECs, and restoration of TEC differentiation. Incomplete resolution or persistence of inflammation can lead to failed tubular repair, fibrosis, and chronic kidney disease. Despite extensive research in animal models, translating preclinical findings to therapies remains challenging, emphasizing the need for integrated multiomic approaches to advance AKI understanding and treatment.

Authors

Megan L. Baker, Lloyd G. Cantley

×

Figure 3

Resolution of AKI.

Options: View larger image (or click on image) Download as PowerPoint
Resolution of AKI.
Immediately following injury, dying cells form casts ...
Immediately following injury, dying cells form casts in the tubular lumen in association with Tamm-Horsfall protein while surviving TECs recruit proinflammatory macrophages and lymphocytes to the tubulointerstitium. (Left) With successful repair and recovery after AKI, casts are cleared and proinflammatory macrophages shift to a proreparative phenotype that promotes TEC proliferation and dampens the immune response, allowing TECs to redifferentiate and restore tubule architecture and function. A small subset of Pax2+ tubular progenitors also contribute to regeneration of necrotic epithelial regions (199). (Right) If injury to a particular tubule or region is severe or sustained, the local immune response is amplified with enhanced recruitment of proinflammatory T cells and B cells into the interstitium and persistence of proinflammatory macrophage populations. This can lead to tubular cell G2/M arrest and adoption of a senescence-associated secretory phenotype with release of inflammatory cytokines, growth factors, proteases, and immune modulators that recruit additional proinflammatory macrophages and lymphocytes that sustain the local inflammatory response and can lead to secondary injury to adjacent tubules. This persistent inflammatory milieu promotes prolymphangiogenic signaling, ongoing TEC injury, profibrotic signaling, and progressive impairment of GFR.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts